June 23, 2022 Blue Fin Group Releases Explanatory Video on Impacts and Future of Public Health Service 340B Program Blue Fin Group announced the availability of an in-depth video by Principal Consultant Timothy Paine that explores the Public Health Service 340B program, its evolution over 30 years, and what is expected in the coming decade.
May 11, 2022 IntegriChain Pharma Contracts & Pricing Experts to Speak at Upcoming Conferences Four IntegriChain Contracts & Pricing experts will speak at two upcoming conferences: the Medicaid and Government Pricing Congress, being held in person May 23-25 and virtually June 1-2, and the Life Sciences Commercial Contracts and Chargebacks Conference, being held as a hybrid event May 24-25.
April 20, 2022 Registration Opens for Access Insights Conference 2022 IntegriChain opens registration to all pharma manufacturers for the Access Insights Conference 2022, now co-hosted by Blue Fin Group, an IntegriChain Company. The Access Insights Conference will be held October 17-19, 2022, at the Marriott Baltimore Harborside. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry executive and practitioner panels, exclusive ICyte Benchmarks presentations, and strategic and tactical programs focused on driving patient access and therapy commercialization.
April 1, 2022 Blue Fin Group, an IntegriChain Company, Promotes Reena K. Patel to Partner Blue Fin Group, a full-service management consulting firm to the pharmaceutical industry, today announced the promotion of Reena K. Patel to Partner.
March 10, 2022 IntegriChain GTN Expert to Speak at Informa’s Life Sciences Accounting and Reporting Conference IntegriChain Gross-to-Net (GTN) and Life Sciences accounting expert Jen Sharpe will present at Informa’s upcoming Life Sciences Accounting and Reporting Conference.
January 20, 2022 IntegriChain Announces Leadership Changes IntegriChain announced key promotions on its executive leadership team following its recent rapid growth: Josh Halpern is now President and Chief Operating Officer (COO); Brad Burget is now Chief Technology Officer (CTO); Vickie Koshushchenko is now Chief People Officer; and William Roth is General Manager and Managing Partner of Blue Fin Group, an IntegriChain Company.
January 20, 2022 IntegriChain Acquires Blue Fin Group, Combining Therapy Commercialization Expertise with Leading Technology, Data, and Business Operations IntegriChain has acquired Blue Fin Group, a full-service professional management consulting firm delivering research, strategy, and implementation services to help manufacturers optimize access. Blue Fin Group’s team of nearly 45 consultants and professionals with expertise in market access, drug commercialization, channel strategy, patient funnel pull through, and GTN optimization will operate as an independent division of IntegriChain.
December 15, 2021 IntegriChain Secures Leadership in State Price Transparency Reporting IntegriChainhas secured leadership in State Price Transparency Reporting for Life Sciences manufacturers. Nearly 80 Life Sciences manufacturer customers rely on IntegriChain’s team of 12 subject matter experts on staff to advise and implement reporting programs. In addition, IntegriChain has generated more than 500 reports to state agencies on behalf of its Life Sciences manufacturer customers to meet the transparency requirements.
December 8, 2021 IntegriChain Presents Annual Customer Awards to Paratek, Agile, AVEO, Moderna, Apellis, and Novartis IntegriChain announces its annual customer awards to innovators and visionaries in market access and commercialization: Market Access Visionary Award to Paratek Pharmaceuticals, Lighthouse Award to Agile Therapeutics, Zero to Launch Award to AVEO Oncology, the Launch Innovator Award to Moderna, the Patient and Channel Data Trailblazer to Apellis Pharmaceuticals, and an individual award, the ICyte Power User Award, to Jane Daly, Manager of Demand Management at Novartis Pharmaceuticals.
